2022 Q4 Form 20-F Financial Statement

#000117891323001460 Filed on April 20, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $5.120M $17.65M $3.034M
YoY Change 68.75% 43.87% -74.22%
Cost Of Revenue $3.480M $11.26M $1.372M
YoY Change 153.64% 85.73% -77.83%
Gross Profit $1.640M $6.388M $1.662M
YoY Change -1.32% 2.97% -70.22%
Gross Profit Margin 32.03% 36.19% 54.78%
Selling, General & Admin $1.870M $7.843M $1.687M
YoY Change 10.85% 35.13% -70.89%
% of Gross Profit 114.02% 122.78% 101.5%
Research & Development $660.0K $3.412M $892.0K
YoY Change -26.01% 23.49%
% of Gross Profit 40.24% 53.41% 53.67%
Depreciation & Amortization $2.691M
YoY Change 20.78%
% of Gross Profit 42.13%
Operating Expenses $3.670M $12.39M $6.264M
YoY Change -41.41% -4.23% -32.86%
Operating Profit -$2.030M -$6.005M -$4.602M
YoY Change -55.89% -10.87% 22.75%
Interest Expense $1.530M -$1.750M -$830.0K
YoY Change -284.34% -48.47% -79.82%
% of Operating Profit
Other Income/Expense, Net -$1.751M
YoY Change -48.44%
Pretax Income -$500.0K -$7.756M -$5.432M
YoY Change -90.8% -23.46% -30.91%
Income Tax -$300.0K -$299.0K $0.00
% Of Pretax Income
Net Earnings -$200.0K -$7.457M -$5.432M
YoY Change -96.32% -26.45% -30.95%
Net Earnings / Revenue -3.91% -42.25% -179.04%
Basic Earnings Per Share -$2.00
Diluted Earnings Per Share -$0.05 -$2.00 -$121.3K
COMMON SHARES
Basic Shares Outstanding 4.206M shares 3.691M shares
Diluted Shares Outstanding 3.691M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.040M $4.040M $3.537M
YoY Change 14.22% 14.22% 12.64%
Cash & Equivalents $4.042M $4.040M $3.537M
Short-Term Investments
Other Short-Term Assets $5.970M $5.970M $6.559M
YoY Change -8.98% -8.98% 4.78%
Inventory $3.411M $3.410M $3.561M
Prepaid Expenses $224.0K $209.0K
Receivables $10.85M $10.85M $11.06M
Other Receivables $2.020M $2.020M $1.390M
Total Short-Term Assets $26.29M $26.29M $26.11M
YoY Change 0.7% 0.7% 4.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.640M $1.640M $1.804M
YoY Change -9.09% -9.09% 31.68%
Goodwill $7.026M $7.026M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $980.0K $980.0K $689.0K
YoY Change 42.24% 42.24% -6.89%
Total Long-Term Assets $15.75M $15.75M $16.01M
YoY Change -1.63% -1.63% 3.97%
TOTAL ASSETS
Total Short-Term Assets $26.29M $26.29M $26.11M
Total Long-Term Assets $15.75M $15.75M $16.01M
Total Assets $42.04M $42.04M $42.12M
YoY Change -0.19% -0.19% 4.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.270M $1.270M $1.395M
YoY Change -8.96% -8.96% -51.22%
Accrued Expenses $2.190M $2.190M $3.678M
YoY Change -40.46% -40.46% -47.61%
Deferred Revenue
YoY Change
Short-Term Debt $900.0K $900.0K $207.0K
YoY Change 334.78% 334.78% -97.13%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.239M $5.240M $5.603M
YoY Change -6.5% -6.48% -71.41%
LONG-TERM LIABILITIES
Long-Term Debt $32.60M $32.60M $30.45M
YoY Change 7.06% 7.06% 103.69%
Other Long-Term Liabilities $900.0K $900.0K $1.503M
YoY Change -40.12% -40.12% 111.69%
Total Long-Term Liabilities $33.67M $33.50M $31.95M
YoY Change 5.37% 4.84% 104.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.239M $5.240M $5.603M
Total Long-Term Liabilities $33.67M $33.50M $31.95M
Total Liabilities $38.91M $38.91M $37.73M
YoY Change 3.13% 3.14% 6.48%
SHAREHOLDERS EQUITY
Retained Earnings -$102.9M -$95.47M
YoY Change 7.81%
Common Stock $106.1M $99.86M
YoY Change 6.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.131M $3.130M $4.392M
YoY Change
Total Liabilities & Shareholders Equity $42.04M $42.04M $42.12M
YoY Change -0.19% -0.19% 4.41%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$200.0K -$7.457M -$5.432M
YoY Change -96.32% -26.45% -30.95%
Depreciation, Depletion And Amortization $2.691M
YoY Change 20.78%
Cash From Operating Activities -$4.654M
YoY Change -50.56%
INVESTING ACTIVITIES
Capital Expenditures $524.0K
YoY Change -131.13%
Acquisitions
YoY Change
Other Investing Activities -$50.00K
YoY Change -213.64%
Cash From Investing Activities -$2.189M
YoY Change 33.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.744M
YoY Change -42.38%
NET CHANGE
Cash From Operating Activities -$4.654M
Cash From Investing Activities -$2.189M
Cash From Financing Activities $6.744M
Net Change In Cash -$99.00K
YoY Change -115.18%
FREE CASH FLOW
Cash From Operating Activities -$4.654M
Capital Expenditures $524.0K
Free Cash Flow -$5.178M
YoY Change -33.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Registrant Name
EntityRegistrantName
SUPERCOM LTD.
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Auditor Firm
AuditorFirmId
6501
CY2022 dei Auditor Name
AuditorName
Halperin Ilanit
CY2022 dei Auditor Location
AuditorLocation
Tel Aviv, Israel
CY2022Q4 spcb Severance Pay Fund
SeverancePayFund
482000 usd
CY2021Q4 spcb Severance Pay Fund
SeverancePayFund
487000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
501000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
202000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
484000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
882000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
168000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
172000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
269000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
49000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
170000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
170000 usd
CY2022Q4 spcb Accrued Severance Pay
AccruedSeverancePay
523000 usd
CY2021Q4 spcb Accrued Severance Pay
AccruedSeverancePay
529000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
108000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
925000 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.9
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.9
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3691226 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3691226 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2619810 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2619810 shares
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
9580000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2360000 usd
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2733000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
0 usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
5680000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4505000 usd
CY2022Q1 spcb Amount Of Direct Offering Cost
AmountOfDirectOfferingCost
4650000000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
313000 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
440159 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
CY2022Q1 spcb Concurrent Private Placement Of Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Rights
ConcurrentPrivatePlacementOfClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRights
564869 shares
CY2022Q1 spcb Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
7
CY2022 us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
211000 usd
CY2022 us-gaap Severance Costs1
SeveranceCosts1
360000 usd
CY2021 us-gaap Severance Costs1
SeveranceCosts1
385000 usd
CY2021Q4 spcb Authorities Accrued Employee Benefits Current And Noncurrent
AuthoritiesAccruedEmployeeBenefitsCurrentAndNoncurrent
393000 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1713000 shares
CY2022 spcb Operating Leases Expense
OperatingLeasesExpense
817000 usd
CY2021 spcb Operating Leases Expense
OperatingLeasesExpense
714000 usd
CY2022Q4 spcb Liabilities Related To Facilities Current
LiabilitiesRelatedToFacilitiesCurrent
0 usd
CY2021Q4 spcb Liabilities Related To Facilities Current
LiabilitiesRelatedToFacilitiesCurrent
136000 usd
CY2022Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
67000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
0 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
28000 usd
CY2022Q4 spcb Authorities Accrued Employee Benefits Current And Noncurrent
AuthoritiesAccruedEmployeeBenefitsCurrentAndNoncurrent
0 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
475000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
356000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
502000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
303000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1200000 usd
CY2022Q4 spcb Operating Lease Right Of Use Asset Other
OperatingLeaseRightOfUseAssetOther
1200000 usd
CY2021Q4 spcb Operating Lease Right Of Use Asset Other
OperatingLeaseRightOfUseAssetOther
1200000 usd
CY2022Q4 spcb Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
716000 usd
CY2021Q4 spcb Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
318000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
484000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
882000 usd
CY2022Q4 spcb Lease Liabilities Current Accrued Expenses And Other Liabilities
LeaseLiabilitiesCurrentAccruedExpensesAndOtherLiabilities
381000 usd
CY2021Q4 spcb Lease Liabilities Current Accrued Expenses And Other Liabilities
LeaseLiabilitiesCurrentAccruedExpensesAndOtherLiabilities
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
108000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
925000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
489000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
925000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
103000 usd
CY2022Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
423000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1264000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1438000 usd
CY2022 spcb Income Tax Expense Benefit Reconciliation Offset Of Other Noncurrent Assets
IncomeTaxExpenseBenefitReconciliationOffsetOfOtherNoncurrentAssets
-79000 usd
CY2021 spcb Income Tax Expense Benefit Reconciliation Offset Of Other Noncurrent Assets
IncomeTaxExpenseBenefitReconciliationOffsetOfOtherNoncurrentAssets
-56000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
369000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M24D
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.58
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y6M29D
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.15
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
86000 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
103000 usd
CY2022 spcb Increase Decrease In Earn Out Liability
IncreaseDecreaseInEarnOutLiability
0 usd
CY2021 spcb Increase Decrease In Earn Out Liability
IncreaseDecreaseInEarnOutLiability
689000 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1751000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3396000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
564869 shares
CY2022Q3 spcb Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.08

Files In Submission

Name View Source Status
0001178913-23-001460-index-headers.html Edgar Link pending
0001178913-23-001460-index.html Edgar Link pending
0001178913-23-001460.txt Edgar Link pending
0001178913-23-001460-xbrl.zip Edgar Link pending
exhibit_1-3.htm Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
exhibit_15-2.htm Edgar Link pending
exhibit_16-1.htm Edgar Link pending
exhibit_8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
image00003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spcb-20221231.xsd Edgar Link pending
zk2329537.htm Edgar Link pending
spcb-20221231_def.xml Edgar Link unprocessable
spcb-20221231_pre.xml Edgar Link unprocessable
spcb-20221231_cal.xml Edgar Link unprocessable
spcb-20221231_lab.xml Edgar Link unprocessable
zk2329537_htm.xml Edgar Link completed